FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Stokes Healthcare | 802110531 | Tacrolimus | 1 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .2 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .2 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .3 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .3 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | 5 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | 5 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .2 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .2 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .3 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .3 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | 10 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | 10 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Buprenorphine | .5 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Buprenorphine | .5 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Cyclosporine | 10 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Cyclosporine | 10 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Cyclosporine | 20 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Cyclosporine | 20 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Cyclosporine | 20 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Cyclosporine | 10 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Diazepam | 5 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Flurbiprofen | .4 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Hydromorphone | 2 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Idoxuridine | 1 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| US Specialty Formulations LLC | 079181064 | 69389-044 | 69389-044-26 | Medroxyprogesterone Acetate | 150 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| US Specialty Formulations LLC | 079181064 | 69389-055 | 69389-055-23 | Pyridoxine Hydrochloride; Riboflavin 5'-Phosphate Sodium; Chromic Chloride; Thiamine Hydrochloride; Methylcobalamin; Niacinamide Hydrochloride | 20 mg/1 mL; .5 mg/1 mL; 50 ug/1 mL; 20 mg/1 mL; .5 mg/1 mL; 20 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| US Specialty Formulations LLC | 079181064 | 69389-064 | 69389-064-22 | Sarracenia Purpurea | 5 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate | .05 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate | .05 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate | .01 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate | .01 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate | .01 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate | .01 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate | .01 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate | .005 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate | .02 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; .625 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .003 mg/1 mL; 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Advanced Pharma, Inc.(556209968)" | Gentamicin Sulfate | .3 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 |